{
    "2021-04-20": [
        [
            {
                "time": "",
                "original_text": "齐鲁引进MUC1 ADC药物；先声药业CDK4/6抑制剂新适应证获批临床；百济神州开启市县级肿瘤日间诊疗阳光行动",
                "features": {
                    "keywords": [
                        "MUC1 ADC药物",
                        "先声药业",
                        "CDK4/6抑制剂",
                        "新适应证",
                        "百济神州",
                        "市县级肿瘤日间诊疗",
                        "阳光行动"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "增量资金集结造势，谁是基金新宠",
                "features": {
                    "keywords": [
                        "增量资金",
                        "基金",
                        "新宠"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}